Fig. 1: In vitro sensitivity to trastuzumab and T-DM1.
From: RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
Relative viability (MTT) of SK-BR-3, SKOV-3, AU-565, HCC1954, and MDA-MB-453 following 72 h treatments with indicated drugs. The sigmoid curve fit model a/(1 + exp(−(x − x0)/b)) was used for T-DM1. Data points represent the observed values of three independent experiments, the bar represents the average and the error bars represent the SD(trastuzumab). Source data are provided as a Source Data file.
